Morning Overview on MSN

Pfizer and BioNTech pause US COVID vaccine trial after slow enrollment

Pfizer and BioNTech have paused a large U.S. clinical trial designed to test their updated COVID-19 vaccine in healthy adults ...
Seeking Alpha

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...

Pfizer, BioNTech hit pause on COVID shot trial as enrollment falls flat

Pfizer Inc PFE and its German COVID-19 vaccine partner BioNTech SE BNTX have reportedly halted recruitment for a large U.S.
Morningstar

Pfizer Canada, BioNTech Get Canadian Approval for Updated Covid-19 Vaccine

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
AOL

Pfizer to outsource some drug production, focus on coronavirus vaccine

(Reuters) - Pfizer Inc <PFE.N> said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to ...
Reuters

COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval

FRANKFURT (Reuters) - Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty ...